HLXC News & Events

Helix Acquisition Corp. III priced its upsized initial public offering of 15M Class A ordinary shares at $10.00 per share. The shares are listed on The Nasdaq Global Market and trade under the ticker symbol "HLXC" beginning today. The special purpose acquisition company may pursue an initial business combination target in any business or industry, but intends to focus on opportunities in healthcare or healthcare-related industries. Leerink Partners and Oppenheimer are serving as the joint bookrunning managers for the offering.

Helix Acquisition Corp. III priced its upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share. The shares will be listed on The Nasdaq Global Market and trade under the ticker symbol "HLXC". The Company expects the offering to be consummated on January 26. The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries. The Company, sponsored by Helix Holdings III, an affiliate of Cormorant Asset Management, is led by Bihua Chen as CEO and Chairperson, and Caleb Tripp as CFO and COO. Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 Class A ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.